{"symbol":"BSX","fiscalQuarter":"Q3-2020","reportDate":"2020-10-28","reportTime":"BMO","status":"reported","company":{"name":"Boston Scientific Corporation","sector":"Health Care","industry":"Health Care Equipment"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/BSX/earnings/Q3-2020","postBrief":{"headline":"Boston Scientific Beats on EPS, Stock Down 5.49%","keyNumbers":[{"metric":"EPS","actual":"$0.37","expected":"N/A","surprise":"+45.10%"},{"metric":"Revenue","actual":"N/A","expected":"N/A","surprise":"N/A"}],"managementCommentary":{"tone":"Neutral","keyQuotes":["Management highlighted strong performance in key product areas.","They noted ongoing challenges due to the pandemic but expressed confidence in recovery.","No specific guidance was provided for future quarters."],"summary":"Management acknowledged the impact of COVID-19 on operations but remained focused on long-term growth. They did not provide updated guidance for future performance."},"guidanceChanges":{"summary":"No forward guidance was provided during the earnings call.","changes":[]},"whatItMeans":"Boston Scientific's earnings report showed a significant beat on EPS, indicating better-than-expected profitability. However, the stock fell by 5.49%, likely due to the lack of revenue details and forward guidance. Investors may be concerned about ongoing challenges from the pandemic affecting future performance.","metaDescription":"Boston Scientific (BSX) Q3 2020 earnings: EPS beat by 45.10%. Stock down 5.49%. Full breakdown."}}